MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 216 filers reported holding MEDIVATION INC in Q4 2013. The put-call ratio across all filers is 1.03 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $175,881,000 | +23.6% | 2,916,924 | -5.8% | 0.12% | +15.9% |
| Q1 2016 | $142,309,000 | +22.6% | 3,095,197 | +28.9% | 0.11% | +33.8% |
| Q4 2015 | $116,047,000 | +17.4% | 2,400,800 | +3.2% | 0.08% | +5.3% |
| Q3 2015 | $98,848,000 | -33.7% | 2,326,056 | +78.2% | 0.08% | -20.0% |
| Q2 2015 | $149,076,000 | -9.3% | 1,305,451 | +2.5% | 0.10% | -6.9% |
| Q1 2015 | $164,420,000 | +75.3% | 1,273,941 | +35.3% | 0.10% | +75.9% |
| Q4 2014 | $93,810,000 | +13.3% | 941,837 | +12.5% | 0.06% | +13.7% |
| Q3 2014 | $82,792,000 | +15.5% | 837,458 | -10.0% | 0.05% | +4.1% |
| Q2 2014 | $71,708,000 | +5.0% | 930,409 | -12.4% | 0.05% | 0.0% |
| Q1 2014 | $68,290,000 | +0.2% | 1,061,935 | -0.5% | 0.05% | 0.0% |
| Q4 2013 | $68,137,000 | -25.5% | 1,067,723 | -30.1% | 0.05% | -27.9% |
| Q3 2013 | $91,502,000 | – | 1,526,899 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |